186 related articles for article (PubMed ID: 20688391)
1. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors.
Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Sindji L; Schiller P; Montero-Menei C; Menei P
Biomaterials; 2010 Nov; 31(32):8393-401. PubMed ID: 20688391
[TBL] [Abstract][Full Text] [Related]
2. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
[TBL] [Abstract][Full Text] [Related]
3. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.
Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Montero-Menei C; Menei P
Biomaterials; 2011 Mar; 32(8):2106-16. PubMed ID: 21183214
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(D,L-lactic acid) nanoparticles.
Kang C; Yuan X; Zhong Y; Pu P; Guo Y; Albadany A; Yu S; Zhang Z; Li Y; Chang J; Sheng J
Technol Cancer Res Treat; 2009 Feb; 8(1):61-70. PubMed ID: 19166243
[TBL] [Abstract][Full Text] [Related]
5. Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival.
Mangraviti A; Tzeng SY; Gullotti D; Kozielski KL; Kim JE; Seng M; Abbadi S; Schiapparelli P; Sarabia-Estrada R; Vescovi A; Brem H; Olivi A; Tyler B; Green JJ; Quinones-Hinojosa A
Biomaterials; 2016 Sep; 100():53-66. PubMed ID: 27240162
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo interactions between glioma and marrow-isolated adult multilineage inducible (MIAMI) cells.
Roger M; Clavreul A; Sindji L; Chassevent A; Schiller PC; Montero-Menei CN; Menei P
Brain Res; 2012 Sep; 1473():193-203. PubMed ID: 22819930
[TBL] [Abstract][Full Text] [Related]
8. Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages.
Almouazen E; Bourgeois S; Boussaïd A; Valot P; Malleval C; Fessi H; Nataf S; Briançon S
Int J Pharm; 2012 Jul; 430(1-2):207-15. PubMed ID: 22465633
[TBL] [Abstract][Full Text] [Related]
9. Exploiting macrophages as targeted carrier to guide nanoparticles into glioma.
Pang L; Qin J; Han L; Zhao W; Liang J; Xie Z; Yang P; Wang J
Oncotarget; 2016 Jun; 7(24):37081-37091. PubMed ID: 27213597
[TBL] [Abstract][Full Text] [Related]
10. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
11. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
12. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
[TBL] [Abstract][Full Text] [Related]
13. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of Cbfa-1-targeting siRNA and SOX9 protein using PLGA nanoparticles to induce chondrogenesis of human mesenchymal stem cells.
Jeon SY; Park JS; Yang HN; Lim HJ; Yi SW; Park H; Park KH
Biomaterials; 2014 Sep; 35(28):8236-48. PubMed ID: 24965885
[TBL] [Abstract][Full Text] [Related]
15. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
Kang T; Gao X; Hu Q; Jiang D; Feng X; Zhang X; Song Q; Yao L; Huang M; Jiang X; Pang Z; Chen H; Chen J
Biomaterials; 2014 May; 35(14):4319-32. PubMed ID: 24565520
[TBL] [Abstract][Full Text] [Related]
16. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.
Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J
Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434
[TBL] [Abstract][Full Text] [Related]
17. Tumor tropic delivery of doxorubicin-polymer conjugates using mesenchymal stem cells for glioma therapy.
Zhang X; Yao S; Liu C; Jiang Y
Biomaterials; 2015 Jan; 39():269-81. PubMed ID: 25468377
[TBL] [Abstract][Full Text] [Related]
18. Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models.
Bexell D; Gunnarsson S; Svensson A; Tormin A; Henriques-Oliveira C; Siesjö P; Paul G; Salford LG; Scheding S; Bengzon J
Neurosurgery; 2012 Mar; 70(3):731-9. PubMed ID: 21869725
[TBL] [Abstract][Full Text] [Related]
19. Aggrecan- and COMP-loaded poly-(lactic-co-glycolic acid) nanoparticles stimulate chondrogenic differentiation of human mesenchymal stem cells.
Jeon SY; Park JS; Yang HN; Woo DG; Park KH
Stem Cells Dev; 2014 Feb; 23(3):305-17. PubMed ID: 24028375
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells show little tropism for the resting and differentiated cancer stem cell-like glioma cells.
Liu Z; Jiang Z; Huang J; Huang S; Li Y; Sheng F; Yu S; Yu S; Liu X
Int J Oncol; 2014 Apr; 44(4):1223-32. PubMed ID: 24481670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
